These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34298557)

  • 21. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia.
    Hori M; Takahashi A; Hosoda K; Ogura M; Harada-Shiba M
    J Clin Endocrinol Metab; 2023 Jan; 108(2):422-432. PubMed ID: 36190978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the genetic burden of familial hypercholesterolemia in a large middle eastern biobank.
    Gandhi GD; Aamer W; Krishnamoorthy N; Syed N; Aliyev E; Al-Maraghi A; Kohailan M; Alenbawi J; Elanbari M; ; Mifsud B; Mokrab Y; Abi Khalil C; Fakhro KA
    J Transl Med; 2022 Nov; 20(1):502. PubMed ID: 36329474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
    Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
    Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.
    Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z
    J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina.
    Corral P; Bañares V; Sáenz B; Zago V; Sarobe A; López G; Berg G; Schreier L
    Arch Cardiol Mex; 2020; 90(2):130-136. PubMed ID: 32897268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
    Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
    J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients With
    Doi T; Hori M; Harada-Shiba M; Kataoka Y; Onozuka D; Nishimura K; Nishikawa R; Tsuda K; Ogura M; Son C; Miyamoto Y; Noguchi T; Shimokawa H; Yasuda S
    J Am Heart Assoc; 2021 Feb; 10(4):e018263. PubMed ID: 33533259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
    Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W
    Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The
    Meshkov A; Ershova A; Kiseleva A; Zotova E; Sotnikova E; Petukhova A; Zharikova A; Malyshev P; Rozhkova T; Blokhina A; Limonova A; Ramensky V; Divashuk M; Khasanova Z; Bukaeva A; Kurilova O; Skirko O; Pokrovskaya M; Mikova V; Snigir E; Akinshina A; Mitrofanov S; Kashtanova D; Makarov V; Kukharchuk V; Boytsov S; Yudin S; Drapkina O
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33418990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features.
    Bertolini S; Calandra S; Arca M; Averna M; Catapano AL; Tarugi P;
    Atherosclerosis; 2020 Nov; 312():72-78. PubMed ID: 32977124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
    Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
    J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
    Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
    J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
    Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
    Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach.
    de Freitas RCC; Bortolin RH; Borges JB; de Oliveira VF; Dagli-Hernandez C; Marçal EDSR; Bastos GM; Gonçalves RM; Faludi AA; Silbiger VN; Luchessi AD; Hirata RDC; Hirata MH
    Mol Biol Rep; 2023 Nov; 50(11):9165-9177. PubMed ID: 37776414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
    Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
    Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.